vs
康美（CNMD）与FONAR CORP（FONR）财务数据对比。点击上方公司名可切换其他公司
康美的季度营收约是FONAR CORP的14.6倍（$373.2M vs $25.5M）。康美同比增速更快（7.9% vs 2.4%）。康美自由现金流更多（$41.2M vs $-227.0K）。过去两年康美的营收复合增速更高（9.3% vs -0.3%）
康美公司是一家上市的美国医疗设备制造商，主营骨科、腹腔镜、普通外科相关医疗器械以及各类患者护理产品，总部现位于佛罗里达州拉戈，2022年7月前设于纽约州尤蒂卡。该品牌秉持以人为本的文化，以助力医疗合作方及其服务的患者为核心使命，在美国和墨西哥都设有生产基地。
FONAR是一家专业医疗技术企业，专注于设计、制造及销售包括立式、开放式在内的创新磁共振成像（MRI）设备，主要服务美国的医院、影像诊断中心及医疗机构，为临床诊断提供高精度扫描解决方案。
CNMD vs FONR — 直观对比
营收规模更大
CNMD
是对方的14.6倍
$25.5M
营收增速更快
CNMD
高出5.5%
2.4%
自由现金流更多
CNMD
多$41.5M
$-227.0K
两年增速更快
CNMD
近两年复合增速
-0.3%
损益表 — Q4 2025 vs Q2 2026
| 指标 | | |
|---|---|---|
| 营收 | $373.2M | $25.5M |
| 净利润 | — | $2.1M |
| 毛利率 | 58.5% | — |
| 营业利润率 | 9.8% | 13.5% |
| 净利率 | — | 8.0% |
| 营收同比 | 7.9% | 2.4% |
| 净利润同比 | — | 4.7% |
| 每股收益（稀释后） | $0.54 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CNMDFONR
| Q4 25 | $373.2M | $25.5M | ||
| Q3 25 | $337.9M | $26.0M | ||
| Q2 25 | $342.3M | $27.3M | ||
| Q1 25 | $321.3M | $27.2M | ||
| Q4 24 | $345.9M | $24.9M | ||
| Q3 24 | $316.7M | $25.0M | ||
| Q2 24 | $332.1M | $25.9M | ||
| Q1 24 | $312.3M | $25.7M |
净利润CNMDFONR
| Q4 25 | — | $2.1M | ||
| Q3 25 | $2.9M | $2.3M | ||
| Q2 25 | $21.4M | $729.3K | ||
| Q1 25 | $6.0M | $2.5M | ||
| Q4 24 | — | $2.0M | ||
| Q3 24 | $49.0M | $3.1M | ||
| Q2 24 | $30.0M | $830.4K | ||
| Q1 24 | $19.7M | $1.9M |
毛利率CNMDFONR
| Q4 25 | 58.5% | — | ||
| Q3 25 | 49.2% | — | ||
| Q2 25 | 55.0% | — | ||
| Q1 25 | 55.3% | — | ||
| Q4 24 | 57.3% | — | ||
| Q3 24 | 56.5% | — | ||
| Q2 24 | 55.3% | — | ||
| Q1 24 | 55.1% | — |
营业利润率CNMDFONR
| Q4 25 | 9.8% | 13.5% | ||
| Q3 25 | 3.5% | 14.1% | ||
| Q2 25 | 11.1% | 5.3% | ||
| Q1 25 | 5.0% | 15.2% | ||
| Q4 24 | 15.2% | 11.9% | ||
| Q3 24 | 20.7% | 21.0% | ||
| Q2 24 | 14.2% | 7.4% | ||
| Q1 24 | 11.2% | 16.8% |
净利率CNMDFONR
| Q4 25 | — | 8.0% | ||
| Q3 25 | 0.8% | 8.7% | ||
| Q2 25 | 6.3% | 2.7% | ||
| Q1 25 | 1.9% | 9.2% | ||
| Q4 24 | — | 7.9% | ||
| Q3 24 | 15.5% | 12.6% | ||
| Q2 24 | 9.0% | 3.2% | ||
| Q1 24 | 6.3% | 7.3% |
每股收益（稀释后）CNMDFONR
| Q4 25 | $0.54 | — | ||
| Q3 25 | $0.09 | — | ||
| Q2 25 | $0.69 | — | ||
| Q1 25 | $0.19 | — | ||
| Q4 24 | $1.09 | — | ||
| Q3 24 | $1.57 | — | ||
| Q2 24 | $0.96 | — | ||
| Q1 24 | $0.63 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $121.0K |
| 总债务越低越好 | $834.2M | — |
| 股东权益账面价值 | $1.0B | $176.9M |
| 总资产 | $2.3B | $217.2M |
| 负债/权益比越低杠杆越低 | 0.81× | — |
8季度趋势，按日历期对齐
现金及短期投资CNMDFONR
| Q4 25 | — | $121.0K | ||
| Q3 25 | — | $122.0K | ||
| Q2 25 | — | $56.5M | ||
| Q1 25 | — | $123.0K | ||
| Q4 24 | — | $121.0K | ||
| Q3 24 | — | $136.0K | ||
| Q2 24 | — | $56.5M | ||
| Q1 24 | — | $134.0K |
总债务CNMDFONR
| Q4 25 | $834.2M | — | ||
| Q3 25 | $853.0M | — | ||
| Q2 25 | $881.1M | — | ||
| Q1 25 | $891.4M | — | ||
| Q4 24 | $905.1M | — | ||
| Q3 24 | $940.1M | — | ||
| Q2 24 | $965.2M | $66.9K | ||
| Q1 24 | $990.1M | — |
股东权益CNMDFONR
| Q4 25 | $1.0B | $176.9M | ||
| Q3 25 | $1.0B | $174.9M | ||
| Q2 25 | $1.0B | $172.6M | ||
| Q1 25 | $977.6M | $171.9M | ||
| Q4 24 | $962.7M | $169.8M | ||
| Q3 24 | $932.9M | $168.7M | ||
| Q2 24 | $881.8M | $166.0M | ||
| Q1 24 | $854.7M | $165.8M |
总资产CNMDFONR
| Q4 25 | $2.3B | $217.2M | ||
| Q3 25 | $2.3B | $218.4M | ||
| Q2 25 | $2.3B | $216.9M | ||
| Q1 25 | $2.3B | $214.9M | ||
| Q4 24 | $2.3B | $208.0M | ||
| Q3 24 | $2.3B | $212.3M | ||
| Q2 24 | $2.3B | $214.2M | ||
| Q1 24 | $2.3B | $209.6M |
负债/权益比CNMDFONR
| Q4 25 | 0.81× | — | ||
| Q3 25 | 0.85× | — | ||
| Q2 25 | 0.88× | — | ||
| Q1 25 | 0.91× | — | ||
| Q4 24 | 0.94× | — | ||
| Q3 24 | 1.01× | — | ||
| Q2 24 | 1.09× | 0.00× | ||
| Q1 24 | 1.16× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $46.3M | $171.0K |
| 自由现金流经营现金流 - 资本支出 | $41.2M | $-227.0K |
| 自由现金流率自由现金流/营收 | 11.0% | -0.9% |
| 资本支出强度资本支出/营收 | 1.4% | 1.6% |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $150.9M | $5.7M |
8季度趋势，按日历期对齐
经营现金流CNMDFONR
| Q4 25 | $46.3M | $171.0K | ||
| Q3 25 | $53.7M | $1.7M | ||
| Q2 25 | $29.1M | $4.2M | ||
| Q1 25 | $41.5M | $3.1M | ||
| Q4 24 | $43.3M | $2.2M | ||
| Q3 24 | $51.2M | $1.7M | ||
| Q2 24 | $43.3M | $4.6M | ||
| Q1 24 | $29.1M | $2.8M |
自由现金流CNMDFONR
| Q4 25 | $41.2M | $-227.0K | ||
| Q3 25 | $48.5M | $-177.0K | ||
| Q2 25 | $23.4M | $3.6M | ||
| Q1 25 | $37.8M | $2.6M | ||
| Q4 24 | $39.3M | $1.5M | ||
| Q3 24 | $47.8M | $-148.0K | ||
| Q2 24 | $39.7M | $4.2M | ||
| Q1 24 | $27.1M | $2.6M |
自由现金流率CNMDFONR
| Q4 25 | 11.0% | -0.9% | ||
| Q3 25 | 14.4% | -0.7% | ||
| Q2 25 | 6.8% | 13.1% | ||
| Q1 25 | 11.8% | 9.4% | ||
| Q4 24 | 11.4% | 6.0% | ||
| Q3 24 | 15.1% | -0.6% | ||
| Q2 24 | 12.0% | 16.1% | ||
| Q1 24 | 8.7% | 10.2% |
资本支出强度CNMDFONR
| Q4 25 | 1.4% | 1.6% | ||
| Q3 25 | 1.5% | 7.2% | ||
| Q2 25 | 1.7% | 2.4% | ||
| Q1 25 | 1.2% | 2.2% | ||
| Q4 24 | 1.2% | 3.0% | ||
| Q3 24 | 1.1% | 7.2% | ||
| Q2 24 | 1.1% | 1.6% | ||
| Q1 24 | 0.7% | 0.7% |
现金转化率CNMDFONR
| Q4 25 | — | 0.08× | ||
| Q3 25 | 18.78× | 0.75× | ||
| Q2 25 | 1.36× | 5.79× | ||
| Q1 25 | 6.88× | 1.26× | ||
| Q4 24 | — | 1.14× | ||
| Q3 24 | 1.05× | 0.53× | ||
| Q2 24 | 1.44× | 5.54× | ||
| Q1 24 | 1.48× | 1.50× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CNMD
| Transferred At Point In Time | $358.5M | 96% |
| Transferred Over Time | $14.7M | 4% |
FONR
| Managementof Diagnostic Imaging Centers | $23.2M | 91% |
| Manufacturingand Servicingof Medical Equipment | $2.4M | 9% |
